Cardinal Health (CAH) delivered mixed results in Q4 FY2026 on revenue of $63.7B versus the $65.2B estimate (+6.1% YoY) and EPS of $2.91. The next Cardinal Health (CAH) earnings date is Nov 5, 2026. Below is the full Cardinal Health earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
Cardinal Health (CAH) Earnings Analysis — key stats
Next earnings date
Nov 5, 2026
Latest reported quarter
Q4 FY2026
Earnings verdict
Mixed
EPS beat rate
7 of last 8 (quarters above estimate)
Avg next-day move
±6.1% (over the last 8 reports)
Post-earnings direction
Up 4 / Down 4 (of the last 8 reports)
Implied move (next report)
±4.6% (options-derived · into Nov 5, 2026)
Institutional ownership
88.3% (13F as of 2026-06-30)
Top 10 holders
44.9% (of shares outstanding)
Insider activity
0 buys / 12 sells (recent Form 4 filings)
Revenue
$63.7B (vs $65.2B est · -2.3% surprise · +6.1% YoY)
EPS
$2.91 (vs $2.42 est · +20.2% surprise · +71.0% YoY)
Share price
$251.03 (-1.8%)
Market cap
$58.1B
Cardinal Health (CAH) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q1 FY2027
$63.7B vs $65.2B est
$2.91 vs $2.42 est
+20.2%
-1.3%
Mixed
Q4 FY2026
$60.9B vs $62.1B est
$3.17 vs $2.79 est
+13.6%
-3.7%
Mixed
Q3 FY2026
$65.6B vs $65.1B est
$2.63 vs $2.34 est
+12.4%
+9.4%
Mixed
Q2 FY2026
$64.0B vs $59.2B est
$2.55 vs $2.18 est
+17.0%
+16.0%
Beat
Q1 FY2026
$60.2B vs $60.9B est
$2.08 vs $2.04 est
+2.0%
-6.1%
In line
Q4 FY2025
$54.9B vs $55.4B est
$2.35 vs $2.17 est
+8.3%
+5.8%
Mixed
Q3 FY2025
$55.3B vs $55.0B est
$1.93 vs $1.74 est
+10.9%
-3.2%
Mixed
Q2 FY2025
$52.3B vs $50.9B est
$1.88 vs $1.62 est
+16.0%
+3.1%
Beat
Top institutional holders
Holder
% outstanding
Shares
Value
QoQ change
Blackrock, INC.
11.2%
26.5M
$6.3B
-7.0%
Vanguard Capital Management LLC
6.5%
15.3M
$3.6B
+0.0%
Wellington Management Group Llp
6.3%
14.9M
$3.5B
+247.5%
Vanguard Portfolio Management LLC
5.8%
13.7M
$3.3B
-0.1%
State Street Corp
5.1%
12.0M
$2.8B
-0.9%
Geode Capital Management, LLC
2.7%
6.5M
$1.5B
-1.6%
Invesco Ltd.
2.0%
4.7M
$1.1B
+35.0%
Morgan Stanley
2.0%
4.6M
$1.1B
-6.6%
Wcm Investment Management, LLC
1.7%
4.1M
$971.4M
+2.6%
Norges Bank
1.6%
3.7M
$885.2M
+100.0%
Recent insider transactions
Insider
Role
Date
Type
Shares
Value
Scherer Mary C.
officer: Chief Accounting Officer
2026-08-19
Sell
100
$23740
Scherer Mary C.
officer: Chief Accounting Officer
2026-08-19
Sell
2K
$522733
Hollar Jason M.
officer: Chief Executive Officer
2026-08-18
Sell
21K
$5.0M
Hollar Jason M.
officer: Chief Executive Officer
2026-08-18
Sell
30K
$7.0M
Hollar Jason M.
officer: Chief Executive Officer
2026-08-18
Sell
16K
$3.8M
Hollar Jason M.
officer: Chief Executive Officer
2026-08-18
Sell
12K
$3.0M
Hollar Jason M.
officer: Chief Executive Officer
2026-08-19
Sell
6K
$1.4M
Hollar Jason M.
officer: Chief Executive Officer
2026-08-19
Sell
3K
$809941
What you'll find
Next Cardinal Health (CAH) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Cardinal Health reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Cardinal Health (CAH)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Cardinal Health's next earnings date?
Cardinal Health's (CAH) next scheduled earnings date is Nov 5, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Cardinal Health (CAH) beat or miss earnings?
In Q4 FY2026, Cardinal Health (CAH) posted mixed results — revenue of $63.7B versus the $65.2B estimate (-2.3% surprise) and EPS of $2.91 versus $2.42 expected (+20.2% surprise). Magnisto decodes every Cardinal Health (CAH) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Cardinal Health beat earnings estimates?
Over its last 8 reported quarters, Cardinal Health (CAH) beat Wall Street EPS estimates 7 times, most recently a mixed result in Q1 FY2027. Magnisto tracks every Cardinal Health (CAH) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Cardinal Health stock move after earnings?
Over its last 8 quarterly reports, Cardinal Health (CAH) moved an average of ±6.1% the day after earnings — ranging from -6.1% (Q1 FY2026) to +16.0% (Q2 FY2026). The stock rose after 4 of those 8 reports and fell after 4. Heading into its next report on Nov 5, 2026, options-implied volatility is pricing in a move of roughly ±4.6% (derived). Magnisto tracks the realized post-earnings move for every Cardinal Health (CAH) quarter alongside the beat/miss verdict — past moves don't predict the next one.
Who are the largest shareholders of Cardinal Health?
Institutions hold about 88.3% of Cardinal Health's (CAH) shares outstanding as of the 2026-06-30 13F quarter. Its largest institutional holders include Blackrock, INC. (11.2%), Vanguard Capital Management LLC (6.5%), Wellington Management Group Llp (6.3%). Magnisto lists Cardinal Health's (CAH) top 13F holders with each stake size and its quarter-over-quarter change.
Are insiders buying or selling Cardinal Health (CAH)?
In the most recent Form 4 filings Magnisto tracks, Cardinal Health (CAH) insiders recorded 0 purchases and 12 sales — net selling. Insider transactions are one signal among many and are often routine (option exercises or scheduled 10b5-1 sales), so Magnisto shows the raw feed for you to judge.
What is the forecast for Cardinal Health (CAH) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Cardinal Health (CAH), anchored to the current $251.03 share price, so you can weigh the bull, base and bear cases for Cardinal Health side by side.
Is Cardinal Health (CAH) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Cardinal Health fits your own thesis and risk profile. This is research, not investment advice.